1-5 of 5
Gulsum Ozet, MD
Close
Sort by
Journal Articles

Efficacy and Safety of Ibrutinib Use in Patients with Chronic Lymphocytic Leukemia in Real World Experiences: Results of a Prospective Multicenter Study

Anil Tombak, MD, Funda Pepedil Tanrikulu, Salih Sertac Durusoy, Emel Gurkan, MD, Emin Kaya, MD, Elif G Umit, MD, Irfan Yavasoglu, MD, Özgür Mehtap, MD, Burak Deveci, Mehmet Ali Ozcan, MD, Hatice Terzi, Mufide Okay, MD, Nilgun Sayinalp, MDPROF., Mehmet Yilmaz, MD, Vahap Okan, Alperen Kizikli, Omer Ozcan, Güven Çetin, Sinan Demircioglu, Ismet Aydogdu, MD, Guray Saydam, MD, Eren arslan Davulcu, Gul Ilhan, Mehmet Ali Ucar, Gulsum Ozet, MD, Seval Akpinar, Burhan Turgut, MD, Ilhami Berber, Erdal Kurtoglu, Mehmet Sönmez, MD, Derya Selim Batur, Rahsan Yildirim, Vildan Ozkocaman, MD, Ahmet Kursat Gunes, Birsen Sahip, Sehmus Ertop, Meltem Akay, Abdulkadir Basturk, Mehmet Hilmi Dogu, Aydan Akdeniz, Ali Unal, MD, Ahmet Seyhanli, Burhan Ferhanoglu, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 5476.
https://doi.org/10.1182/blood-2019-126402
Published: 2019
Journal Articles

Evaluation of Patients with PNH Treated By Eculizumab: Real World Data from Turkey

Fatma Keklik Karadag, MD, Mustafa Nuri Yenerel, MD, Yılmaz Mehmet, MD, Hava uskudar Teke, MD, Vildan Ozkocaman, MD, Tulin Tuglular, MD, Fuat Erdem, MD, Ali Unal, MD, Orhan Ayyildiz, MD, Gulsum Ozet, MD, Melda Ozkan, MD, Emin Kaya, MD, Mesut Ayer, MD, Ozan Salim, MD, Birol Güvenç, MD, Hakan Ozdogu, MD, Özgür Mehtap, MD, Mehmet Sönmez, MD, Nil Güler, MD, Sibel Kabukcu Hacioglu, MD, Ismet Aydogdu, MD, Ozlen Bektas, MD, Selami Kocak Toprak, MD, Lale Kaynar, MD, Munci Yagci, MD, Salih Aksu, MDPROF., Anil Tombak, MD, Volkan Karakus, MD, Irfan Yavasoglu, MD, Birgül Öneç, MD, Mehmet Ali Özcan, MD, Levent Ündar, MD, Rıdvan Ali, MD, Celalettin Ustun, MD, Osman Ilhan, MD, Guray Saydam, MD, Fahri Sahin, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 4805.
https://doi.org/10.1182/blood-2019-128743
Published: 2019
Journal Articles

Splenic Marginal Zone Lymphoma in an East Mediterranean/Middle Eastern Population Cohort: Possible Association with Hepatitis B Instead of Hepatitis C Virus As an Etiologic and Prognostic Factor (ThREG-NHL01 Study)

Tuncay Aslan, Evren Ozdemir, MD, Aysegul Uner, Elif Gungor, Nevin Alayvaz Aslan, Esra Yildizhan, MD, Abdullah Agit, Serdal Korkmaz, MD, Gulsum Akgun Cagliyan, Ibrahim Barista, MD, Esra Ozhamam, Gulsum Emel Pamuk, MD, Mehmet Turgut, MD PhD, Bulent Eser, Gulsum Ozet, MD, Rahsan Yıldırım, Yahya Buyukasik, MD
Journal: Blood
Blood (2016) 128 (22): 5332.
https://doi.org/10.1182/blood.V128.22.5332.5332
Published: 2016
Journal Articles

A Multicenter Experience of Thrombotic Microangiopathies in Turkey: The Turkish Hematology Research and Education Group (ThREG) - TMA01 Study

Emre Tekgunduz, MD, Mehmet Yilmaz, MD, Mehmet Ali Erkurt, MD, Ilhami Kiki, MD, Ali Hakan Kaya, MD, Leylagul Kaynar, MD, Inci Alacacioglu, MD, Guven Cetin, MD, Ibrahim Ozarslan, MD, Irfan Kuku, MD, Gulden Sincan, MD, Ozan Salim, MD, Sinem Namdaroglu, MD, Abdullah Karakuş, MD, Volkan Karakuş, MD, Gulsum Emel Pamuk, MD, Fevzi Altuntas, MD, Hakan Ismail Sari, MD, Gulsum Ozet, MD, Ismet Aydogdu, MD, Vahap Okan, MD, Emin Kaya, MD, Rahsan Yildirim, MD, Esra Yildizhan, MD, Gokhan Ozgur, MD, Osman Ilhami Ozcebe, MD, Bahriye Payzin, MD, Seval Akpinar, MD, Fatih Demirkan, MD
Journal: Blood
Blood (2016) 128 (22): 4933.
https://doi.org/10.1182/blood.V128.22.4933.4933
Published: 2016
Journal Articles

Comparison of ICE (Ifosfamide-Carboplatin-Etoposide) Versus DHAP (Cytosine Arabinoside-Cisplatin-Dexamethasone) as Salvage Chemotherapy in Patients with Relapsed or Refractory Lymphoma.

Yuksel Urun, MD, Huseyin Abali, Md, Berna Oksuzoglu, Md, Burcin Budakoglu, Md, Nuriye Yildirim, Md, Tunc Guler, Md, Gulsum Ozet, Md, Nurullah Zengin, Md
Journal: Blood
Blood (2007) 110 (11): 4438.
https://doi.org/10.1182/blood.V110.11.4438.4438
Published: 2007